← Browse by Condition
Medical Condition

cardiopulmonary bypass

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for cardiopulmonary bypass sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiopulmonary bypass Clinical Trials

How many clinical trials are currently recruiting for cardiopulmonary bypass?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cardiopulmonary bypass, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiopulmonary bypass?
cardiopulmonary bypass research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiopulmonary bypass clinical trial?
Eligibility criteria for cardiopulmonary bypass trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
University of Maryland, Baltimore 1 trial
Taichung Veterans General Hospital 1 trial
Hernán Darío Castro Arias 1 trial
GCP-Service International West GmbH 1 trial
Eurosets S.r.l. 1 trial

Recruiting Clinical Trials

NCT05189262
Recruiting
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
Enrollment
150 pts
Location
United States
Sponsor
University of Maryland, Baltim...
View Trial →
NCT06109155 Phase 4
Recruiting
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
Enrollment
150 pts
Location
Taiwan
Sponsor
Taichung Veterans General Hosp...
View Trial →
NCT07683299
Recruiting
HEMO-INTEGRA: Integrated Intraoperative Hemodynamic Monitoring During Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Study
Enrollment
30 pts
Location
Colombia
Sponsor
Hernán Darío Castro Arias
View Trial →
NCT06279793 Phase 2
Recruiting
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
Enrollment
550 pts
Location
Germany
Sponsor
GCP-Service International West...
View Trial →
NCT07354841
Recruiting
Safety and Performance Evaluation of CPB Venous and Arterial Cannulas
Enrollment
80 pts
Location
Italy
Sponsor
Eurosets S.r.l.
View Trial →

Related Conditions

cardiac surgery (3) kidney injury acute (1) surgery cardiac (1) tranxemic acid (1) activated clotting time (1) heparin (1) hemodynamic monitoring (1) ventricular arterial coupling (1) intensive care unit (1) coronary artery bypass grafting cabg (1) high risk patients (1) elective cardiac surgery (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology